Biocon

Sustainability Report and Carbon Intensity Rankings

Is Biocon doing their part?

Their DitchCarbon score is 61

Biocon has a DitchCarbon Score of 61, indicating a moderate level of sustainability in their operations. This score reflects the company’s efforts to manage and reduce its carbon intensity. A higher score would suggest even greater success in minimizing their environmental impact through lower carbon emissions.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Biocon operates in the services industry, which has a very low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Biocon, located in India, operates in a region with a very high carbon intensity rating. This suggests that the company’s sustainability efforts may be significantly challenged by the high carbon emissions associated with the local energy grid and industrial practices.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Biocon

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

17.15%

...this company is doing 17.15% better in emissions than the industry average.

Founded in 1978 and headquartered in Bengaluru, India, Biocon Ltd. is a leading biopharmaceutical company that specializes in developing innovative and affordable healthcare solutions. The company has made significant strides in the biopharma industry by introducing products such as recombinant human Insulin and novel biologics for chronic diseases like diabetes, cancer, and autoimmune disorders. With a growing global presence, Biocon is expanding its operations with a state-of-the-art facility in Malaysia, aiming to meet the increasing demand for affordable insulin and insulin analogs worldwide.

Compare Biocon with other companies in the same industry –>

emission intelligence's platform recommendations for Biocon

Biocon should enhance its energy efficiency by adopting measures across all forms of purchased energy, potentially reducing its emissions by 30%.

Good news, Biocon has embraced SBTi climate commitments

Biocon has pledged to align its operations and strategies with the Science Based Targets initiative to significantly reduce greenhouse gas emissions. This commitment involves setting science-based environmental targets to limit global warming and transition to a low-carbon economy.

Participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

Biocon

Sustainability Report and Carbon Intensity Rankings

Is Biocon doing their part?

Their DitchCarbon score is 61

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Medium

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on Biocon

...this company is doing 17.15% better in emissions than the industry average.

emission intelligence's platform recommendations for Biocon

Good news, Biocon has embraced SBTi climate commitments

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch